These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17392996)

  • 21. Ask the doctor. A warning on my statin prescription tells me not to drink grapefruit juice or eat grapefruit. Does this mean I can never enjoy this delicious fruit again?
    Lee T
    Harv Heart Lett; 2006 Jul; 16(11):8. PubMed ID: 16850557
    [No Abstract]   [Full Text] [Related]  

  • 22. Grapefruit-drug interactions: can interactions with drugs be avoided?
    Mertens-Talcott SU; Zadezensky I; De Castro WV; Derendorf H; Butterweck V
    J Clin Pharmacol; 2006 Dec; 46(12):1390-416. PubMed ID: 17101740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interaction between digoxin, beta-blockers, calcium antagonists, and other cardiac drugs].
    Hertzeanu H; Pines A
    Harefuah; 1986 Sep; 111(5-6):138-40. PubMed ID: 2879778
    [No Abstract]   [Full Text] [Related]  

  • 24. Adverse cardiovascular drug interactions.
    Opie LH
    Curr Probl Cardiol; 2000 Sep; 25(9):621-76. PubMed ID: 11043147
    [No Abstract]   [Full Text] [Related]  

  • 25. [Some advances in cardiovascular pharmacology (author's transl)].
    Ding GS
    Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):97-103. PubMed ID: 6118953
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine.
    Nakagawa K; Ishizaki T
    Pharmacol Ther; 2000 Apr; 86(1):1-28. PubMed ID: 10760544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: The grapefruit: an old wine in a new glass? Metabolic and cardiovascular perspectives.
    Muller FO
    Cardiovasc J Afr; 2011; 22(1):37. PubMed ID: 21298205
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of grapefruit juice and calcium channel blockers.
    Sica DA
    Am J Hypertens; 2006 Jul; 19(7):768-73. PubMed ID: 16814135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Avoid these with heart medications. Interactions with common foods, beverages, vitamins, and supplements can change how your medicine works.
    Harv Heart Lett; 2013 Jun; 23(10):4-5. PubMed ID: 23926628
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparison of three protocols in the control of cardiovascular response to suspended laryngoscopy in ENT surgery].
    Boussofara M; Chrayti H; Bracco D; Ravussin P
    Tunis Med; 2004 Jan; 82(1):19-24. PubMed ID: 15125352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cardiac medications on ventricular performance: emphasis on evaluation with radionuclide angiography.
    Nestico PF; Hakki AH; Iskandrian AS
    Am Heart J; 1985 May; 109(5 Pt 1):1070-84. PubMed ID: 2859773
    [No Abstract]   [Full Text] [Related]  

  • 32. Drugs used in heart disease. 1. Pharmacology--1.
    Landowski R; Shulman R; Davies R
    Nurs Times; 2002 Apr 30-May 6; 98(18):43-6. PubMed ID: 12035447
    [No Abstract]   [Full Text] [Related]  

  • 33. Interactions between antihypertensive drugs and food.
    Jáuregui-Garrido B; Jáuregui-Lobera I
    Nutr Hosp; 2012; 27(6):1866-75. PubMed ID: 23588433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ask the doctor. I avoid grapefruit juice because my doctor says it affects how my body handles the Lipitor I take for my cholesterol. Should I also stay away from pomelo?
    Lee T
    Harv Heart Lett; 2010 Nov; 21(3):7. PubMed ID: 21162177
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular studies on different classes of soft drugs.
    Juhász A; Bodor N
    Pharmazie; 2000 Mar; 55(3):228-38. PubMed ID: 10756546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular medications in angiogenesis--how to avoid the sting in the tail.
    Ma C; Wang Q; Man Y; Kemmner W
    Int J Cancer; 2012 Sep; 131(6):1249-59. PubMed ID: 22488125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in cardiovascular pharmacology.
    Goldberg LI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S922-7. PubMed ID: 6084150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of reduction in heart rate in cardiovascular disease.
    Hjalmarson A
    Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II3-7. PubMed ID: 9853192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.
    Avezum A; Pais P; Flather MD; Anand S; Yusuf S
    Indian Heart J; 1995; 47(2):95-105. PubMed ID: 7590849
    [No Abstract]   [Full Text] [Related]  

  • 40. Drugs, angioplasty nearly equal for angina relief.
    Harv Heart Lett; 2008 Nov; 19(3):7. PubMed ID: 19024777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.